One study in chronic lymphocytic leukemia (CLL) also suggested that AXL inhibition mediates apoptosis by reducing the expression of the anti-apoptotic protein MCL1 [54]. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.